Mark Eccleston
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
- Hydrogels: synthesis, properties, applications
Papers in
-
- RNA Interference and Gene Delivery 9
- Epigenetics and DNA Methylation 7
- Biopolymer Synthesis and Applications 6
- Advanced biosensing and bioanalysis techniques 5
- RNA modifications and cancer 5
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Nigel K.H. Slater (17 shared papers)Zhilian Yue (10 shared papers)Rongjun Chen (6 shared papers)Clemens F. Kaminski (5 shared papers)Sariah Khormaee (2 shared papers)Johannes Swartling (1 shared paper)Mariëlle Herzog (7 shared papers)Jake Micallef (4 shared papers)
- Journals
- Epigenomics (3 papers)Biomaterials (3 papers)Polymer (3 papers)Annals of Oncology (2 papers)Clinical Epigenetics (2 papers)
- Partner nations
- United KingdomItalyFrance
In The Last Decade
Mark Eccleston
30 papers receiving 799 citations
Peers
Comparison fields: 5 of 79
- Biomaterials 219
- Molecular Medicine 64
- Pharmaceutical Science 51
- Surfaces, Coatings and Films 53
- Molecular Biology 479
Countries citing papers authored by Mark Eccleston
This map shows the geographic impact of Mark Eccleston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Eccleston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Eccleston more than expected).
Fields of papers citing papers by Mark Eccleston
This network shows the impact of papers produced by Mark Eccleston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Eccleston. The network helps show where Mark Eccleston may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Eccleston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 135 | |
| 2 | 2009 | 96 | |
| 3 | 2015 | 88 | |
| 4 | 2005 | 83 | |
| 5 | 2020 | 59 | |
| 6 | 2000 | 47 | |
| 7 | 2005 | 35 | |
| 8 | 2009 | 35 | |
| 9 | 2021 | 33 | |
| 10 | 1999 | 29 | |
| 11 | 2009 | 24 | |
| 12 | 2005 | 24 | |
| 13 | 2006 | 24 | |
| 14 | 2008 | 22 | |
| 15 | 2005 | 19 | |
| 16 | 2003 | 13 | |
| 17 | 2023 | 12 | |
| 18 | 2024 | 9 | |
| 19 | 2022 | 8 | |
| 20 | 2021 | 6 |
About Mark Eccleston
Mark Eccleston is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Materials Chemistry and Organic Chemistry, having authored 32 papers that have together received 827 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Epigenetics and DNA Methylation (7 papers), Biopolymer Synthesis and Applications (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), RNA modifications and cancer (5 papers), Nanoparticle-Based Drug Delivery (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Hydrogels: synthesis, properties, applications (3 papers). The work is most often cited by research in Biomaterials (219 citations), Molecular Medicine (64 citations), Pharmaceutical Science (51 citations), Surfaces, Coatings and Films (53 citations) and Molecular Biology (479 citations). Mark Eccleston has collaborated with scholars based in United Kingdom, Italy and France. Frequent co-authors include Nigel K.H. Slater, Zhilian Yue, Rongjun Chen, Clemens F. Kaminski, Sariah Khormaee, Johannes Swartling, Mariëlle Herzog, Jake Micallef, Marcel Kuiper and Bodil Andersson. Their work appears in journals such as Epigenomics, Biomaterials, Polymer, Annals of Oncology and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.